Accelerated Phase Myeloproliferative Neoplasm

Accelerated Phase Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

80 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06661915	A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)	recruiting	Phase 2	78	National Cancer Institute (NCI)NIH	1	Sep 30, 2026	clinicaltrials
NCT07148947	Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms	recruiting	Phase 2	27	University of WashingtonOTHER	1	Aug 19, 2026